Single-molecule immunosorbent assay as a tool for human immunodeficiency virus-1 antigen detection

Jiangwei Li; Wenjun Xie; Ning Fang; Yeung, Edward S.
May 2009
Analytical & Bioanalytical Chemistry;May2009, Vol. 394 Issue 2, p489
Academic Journal
Ultrasensitive detection and quantification of viral antigen with a novel single-molecule immunosorbent assay (SMISA) was achieved. Antigen from human immunodeficiency virus type 1 (HIV-1), the major etiological agent of acquired immune deficiency syndrome, served as the screening target in this study. The target molecule was sandwiched between a polyclonal capture antibody and a monoclonal detector antibody. The capture antibody was covalently immobilized on (3-glycidoxypropyl) trimethoxy silane-modified glass slides. The detector antibody was conjugated with fluorescent Alexa Fluor 532 labeled secondary antibody prior to being used as a probe for the antigen. Imaging was performed with a total internal reflection fluorescence single-molecule detection system. This technique is demonstrated for detecting HIV-1 p24 antigen down to 0.1 pg/mL with a dynamic range of over four orders of magnitude. A Langmuir isotherm fits the molecule count dependence on the target concentration. The target antigen was further tested in 20% human serum, and the results showed that neither sensitivity nor dynamic range was affected by the biological matrix. SMISA is therefore a promising approach for the early diagnosis of viral induced diseases.


Related Articles

  • Schistosomiasis and HIV in Rural Zimbabwe: Efficacy of Treatment of Schistosomiasis in Individuals with HIV Coinfection. Kallestrup, Per; Zinyama, Rutendo; Gomo, Exnevia; Butterworth, Anthony E.; van Dam, Govert J.; Gerstoft, Jan; Erikstrup, Christian; Ullum, Henrik // Clinical Infectious Diseases;6/15/2006, Vol. 42 Issue 12, p1781 

    Background. There is evidence from experimental models that the praziquantel-induced clearance of schistosomiasis is dependent on the host's immune response. Consequently, human immunodeficiency virus (HIV)-related immunodeficiency may impair the effect of praziquantel treatment. Methods. In a...

  • Comparison the Radiologic Findings of Pulmonary Tuberculosis Among HIV-Seropositive With HIV-Seronegative Patients. Ahmadi, Fatmeh; Salmanzadeh, Shokrollah; Kimyai, Mehdi // Jundishapur Journal of Microbiology;2012, Vol. 5 Issue 2, p421 

    Background: Approximately 1.8 million of the world's population is infected with both M.tuberculosis (TB) and HIV. HIV-seropositive patients with TB may have radiographically atypical presentations. Objectives: This study aimed to determine whether there was any difference in radiological...

  • Preface (Hot Topic: HIV Vaccines Executive Editor: Melissa Pope). Pope, Melissa // Current Molecular Medicine;May2003, Vol. 3 Issue 3, p1 

    Introduces a series of articles on the status of HIV vaccine research as of May 2003. Research status in terms of human and animal studies of putative vaccines; Identification of the types of immune responses that need to be elicited by the various strategies being considered to ensure vaccine...

  • CNE/CME questions.  // AIDS Alert;Oct2009, Vol. 24 Issue 10, p119 

    A quiz concerning human immunodeficiency virus (HIV) patients is presented.

  • Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor. Andrabi, Raiees; Makhdoomi, Muzamil; Luthra, Kalpana // Retrovirology;2013, Vol. 10 Issue Suppl 1, p1 

    An abstract of the article "Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor" by Raiees Andrabi, Muzamil Makhdoomi and Kalpana Luthra is presented.

  • gp41:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p100 

    An encyclopedia entry for "gp41," which refers to the transmembrane segment of the human immunodeficiency virus, is presented.

  • Subtle Mimicry of HLA by HIV-1 GP120 - A Role for Anti HLA Antibodies? Smith, Peter Lawrence; Dalgleish, Angus // Open Autoimmunity Journal;2010 Special Issue 2, p104 

    Human immunodeficiency virus (HIV-1) infection causes progressive immune deficiency by the targeted depletion of CD4+ T cells. The mechanism by which HIV-1 achieves this is not completely understood, however chronic immune activation is understood to be an essential feature of progressive HIV-1...

  • CCR6 Functions as a New Coreceptor for Limited Primary Human and Simian Immunodeficiency Viruses. Islam, Salequl; Shimizu, Nobuaki; Hoque, Sheikh Ariful; Jinno-Oue, Atsushi; Tanaka, Atsushi; Hoshino, Hiroo // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    More than 12 chemokine receptors (CKRs) have been identified as coreceptors for the entry of human immunodeficiency virus type 1 (HIV-1), type 2 (HIV-2), and simian immunodeficiency viruses (SIVs) into target cells. The expression of CC chemokine receptor 6 (CCR6) on Th17 cells and regulatory T...

  • Detection of Antibodies to Human Immunodeficiency Virus (HIV) That Recognize Conformational Epitopes of Glycoproteins 160 and 41 Often Allows for Early Diagnosis of HIV Infection. Jianmin Chen; Liqiang Wang; Chen, Jenny J.-Y.; Sahu, Gautam K; Tyring, Stephen; Ramsey, Keith; Indrikovs, Alexander J.; Petersen, John R.; Paar, David; Cloyd, Miles W. // Journal of Infectious Diseases;8/1/2002, Vol. 186 Issue 3, p321 

    On the basis of human immunodeficiency virus (HIV) needlestick studies, the time to seroconversion for anti-HIV antibodies is 1-9 months (mean, ∼2-3 months). However, an earlier marker of an immune response to HIV often occurs—serum anti-HIV antibodies reactive with live HIV-infected...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics